Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma

• Takeshi Azuma ,

  Roles Funding acquisition, Investigation, Writing – original draft

  * E-mail: tazuma-tky@umin.ac.jp

  Affiliations Department of Urology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, Department of Molecular Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan

  http://orcid.org/0000-0002-4921-2122

  ⨯
• Yujiro Sato,

  Roles Funding acquisition, Investigation

  Affiliation Department of Urology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

  ⨯
• Tetsukuni Ohno,

  Roles Methodology, Writing – review & editing

  Affiliation Department of Molecular Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

  ⨯
• Miyuki Azuma,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Molecular Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

  ⨯
• Haruki Kume

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan

  ⨯